Spotlight
Clinical
News
FDA
CME/CE
First-time generic approvals May 2010
Generic drugs approved by FDA (through April 2010): Losartan potassium tablets in 25-mg, 50-mg, and 100-mg, Losartan potassium and hydrochlorothiazide tablets in 50 mg/12.5 mg, 100 mg/12.5-mg, and 100 mg/25 mg, Hydromorphone hydrochloride injection, Mesna injection
Losartan potassium tablets in 25-mg, 50-mg, and 100-mg strengths (equiv to Cozaar)
TEVA PHARMACEUTICALS
Losartan potassium and hydrochlorothiazide tablets in 50 mg/12.5 mg, 100 mg/12.5-mg, and 100 mg/25 mg strengths (equiv to Hyzaar)
Hydromorphone hydrochloride injection 10 mg/mL in 1-, 5-, and 50-mL doses (equiv to Dilaudid-HP 10 mg/mL injection)
AKORN
Mesna injection in 1 mg per 10 mL multi-dose vials (equiv to Mesnex)
STRIDES ARCOLAB
Related Content
